[PERSON]

John Rim

Featured in 2 tracked stories · first seen 3 months ago

Situations

[QUIET] [BUSINESS] [KR] [US]

Samsung Bio business and ESG developments

2 clusters · 4 sources · last updated 7 days ago

Latest: Samsung Biologics achieves top ESG risk rating from Sustainalytics

Samsung Bioepis and Samsung Biologics have secured significant commercial agreements. Samsung Bioepis entered a partnership with Teva Pharmaceuticals International GmbH to commercialize two FDA-approved biosimilars, Renf